Evidence map›Paper›PMID 26512085›Full record

ArticleJournal of virology2016

A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease.

Joel Oppliger, Joel Ramos da Palma, Dominique J Burri, Eric Bergeron, Abdel-Majid Khatib, Christina F Spiropoulou, Antonella Pasquato, Stefan Kunz

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Structural basis for substrate selectivity by site-one protease revealed by studies with a small-molecule inhibitor.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Joel OppligerInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Joel Ramos da PalmaInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland.
Dominique J BurriInstitute of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Eric BergeronViral Special Pathogens Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID http://orcid.org/0000-0003-3398-8628
Abdel-Majid KhatibUniversité Bordeaux, LAMC, Pessac, France INSERM, UMR 1029, Pessac, France.
Christina F SpiropoulouViral Special Pathogens Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Antonella PasquatoInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland Antonella.Pasquato@chuv.ch Stefan.Kunz@chuv.ch.
Stefan KunzInstitute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland Antonella.Pasquato@chuv.ch Stefan.Kunz@chuv.ch.
University of Lausanne · CHCenters for Disease Control and Prevention · USHarvard University · USUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledArenaviruses are emerging viruses including several causative agents of severe hemorrhagic fevers in humans. The advent of next-generation sequencing technology has greatly accelerated the discovery of novel arenavirus species. However, for many of these viruses, only genetic information is available, and their zoonotic disease potential remains unknown. During the arenavirus life cycle, processing of the viral envelope glycoprotein precursor (GPC) by the cellular subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P) is crucial for productive infection. The ability of newly emerging arenaviruses to hijack human SKI-1/S1P appears, therefore, to be a requirement for efficient zoonotic transmission and human disease potential. Here we implement a newly developed cell-based molecular sensor for SKI-1/S1P to characterize the processing of arenavirus GPC-derived target sequences by human SKI-1/S1P in a quantitative manner. We show that only nine amino acids flanking the putative cleavage site are necessary and sufficient to accurately recapitulate the efficiency and subcellular location of arenavirus GPC processing. In a proof of concept, our sensor correctly predicts efficient processing of the GPC of the newly emergent pathogenic Lujo virus by human SKI-1/S1P and defines the exact cleavage site. Lastly, we employed our sensor to show efficient GPC processing of a panel of pathogenic and nonpathogenic New World arenaviruses, suggesting that GPC cleavage represents no barrier for zoonotic transmission of these pathogens. Our SKI-1/S1P sensor thus represents a rapid and robust test system for assessment of the processing of putative cleavage sites derived from the GPCs of newly discovered arenavirus by the SKI-1/S1P of humans or any other species, based solely on sequence information. IMPORTANCE: Arenaviruses are important emerging human pathogens that can cause severe hemorrhagic fevers with high mortality in humans. A crucial step in productive arenavirus infection of human cells is the processing of the viral envelope glycoprotein by the cellular subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P). In order to break the species barrier during zoonotic transmission and cause severe disease in humans, newly emerging arenaviruses must be able to hijack human SKI-1/S1P efficiently. Here we implement a newly developed cell-based molecular sensor for human SKI-1/S1P to characterize the processing of arenavirus glycoproteins in a quantitative manner. We further use our sensor to correctly predict efficient processing of the glycoprotein of the newly emergent pathogenic Lujo virus by human SKI-1/S1P. Our sensor thus represents a rapid and robust test system with which to assess whether the glycoprotein of any newly emerging arenavirus can be efficiently processed by human SKI-1/S1P, based solely on sequence information.

Indexed as

Protein Processing, Post-TranslationalAnimalsGlycoproteinsHumansLujo virusMolecular Probe TechniquesProprotein ConvertasesSerine EndopeptidasesViral Envelope ProteinsGlycoproteinsmembrane-bound transcription factor peptidase, site 1Proprotein ConvertasesSerine EndopeptidasesViral Envelope Proteins

Identifiers

PMID26512085
PMCPMC4702697
OpenAlexW1885685568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.